Navigation Links
Advanced Health Media Announces Acquisition of Ephikacy, LLC
Date:10/8/2009

BRIDGEWATER, N.J., Oct. 8 /PRNewswire/ -- Advanced Health Media, LLC (AHM) has acquired Ephikacy, LLC, the Chicago-based provider of marketing services and related technology for the pharmaceutical and life sciences industries.

Advanced Health Media is the industry leader in speaker bureau management, supplying automation and compliance management systems to more than 50 pharmaceutical companies and coordinating promotional events for more than 200 brands. The addition of Ephikacy's product and service line expands AHM's offering for marketers and brand teams. Ephikacy's marketing-focused services include speaker bureau branding and design, tactical integration with centralized program registration capabilities, customer data management and performance analytics. The AHM and Ephikacy combination creates a single organization that can satisfy the creative, tactical and information needs of a marketing team within the framework of PFX(TM), AHM's enterprise system for controlled healthcare professional (HCP) interactions and organizational compliance that is now used by the majority of the top 20 pharmaceutical companies to automate and control promotion and HCP interaction.

"With this acquisition, we have created a full-service company that can deliver organizational compliance to our corporate customers without asking brand teams to sacrifice creativity or control over their promotional tactics," said Kevin McMurtry, CEO of Advanced Health Media. "The integration of AHM and Ephikacy will ensure streamlined and seamless compliance while enabling better control and visibility for marketers."

"We are excited to be part of AHM and very enthusiastic about the combined capabilities and resources this acquisition brings to the marketplace," said Ephikacy co-founder Paul Fitzpatrick. "Pharmaceutical marketers are looking for the broad, integrated services that the AHM - Ephikacy partnership delivers." The newly formed partnership will allow Ephikacy to expand its client base as well as provide additional resources for its existing customers. Ephikacy, LLC will continue to operate from its Chicago, IL offices, thus expanding AHM's footprint in the mid-west.

About Advanced Health Media, LLC

Advanced Health Media (AHM) is the leading U.S. provider of speaker-led meeting logistics, state and federal regulatory compliance technology, thought leader development and medical communications. AHM has developed and markets a fully integrated suite of hosted technology solutions and sales support services designed to address the diverse operational and compliance management needs of its clients, including corporate speaker bureau and event management solutions, sales force automation technology, customer relationship management, and compliance tracking and reporting systems. AHM also provides full-service medical communications, including strategic communication strategy, publication planning, scientific meetings and key opinion leader advocacy development. AHM provides services to more than 50 companies in the pharmaceutical sector.

Headquartered in Bridgewater, N.J., with offices in Union and Somerville, N.J., Chesapeake, Virginia, and Chicago, Illinois, AHM is the parent company of AHM Solutions, Centeon Solutions, Embryon, LLC, Cogenix, LLC, ProMedix, LLC, and InsiteResearch, LLC. For more information, please visit the AHM Web site at www.ahmdirect.com.

About Ephikacy, LLC

Ephikacy, LLC is a provider of marketing and communication solutions for the healthcare industry. The company's innovative product and services incorporate state of the art technologies to improve communications among brand teams, speaker bureaus, healthcare professionals and sales forces. Ephikacy, LLC is located in Chicago, Illinois and works with top pharmaceutical and biotechnology companies in the United States. For more information, please visit the website at www.ephikacy.com.

SOURCE Advanced Health Media, LLC


'/>"/>
SOURCE Advanced Health Media, LLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Telik Announces Publication of Positive Phase 1-2a Results of a Multicenter Study of TELCYTA(R) in Combination With Carboplatin and Paclitaxel in Patients With Advanced Non-Small Cell Lung Cancer
2. The Most Advanced Solution for the Reduction of Stretch Marks Based on TriPollar(R) Technology Presented at the Upcoming EADV Congress
3. OPAXIO Produces High Rates of Pathologic Complete Remission in Patients with Advanced Esophageal Cancer; Study Paves Way for Potential Registration Trial as Radiation Sensitizer
4. Medivation Announces Initiation of Phase 3 Clinical Trial of MDV3100 in Advanced Prostate Cancer
5. Phase 3 Trial Shows Denosumab Delayed Skeletal Related Events in Advanced Cancer Patients With Bone Metastases
6. Keryx Biopharmaceuticals Phase 2 Data of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Renal Cell Cancer Selected for Oral Presentation at the Eighth International Kidney Cancer Symposium
7. Medigus and Tower Semiconductor Announce Worlds Smallest Medical Video Camera Based on Advanced CMOS Image Sensor
8. OPAXIO(TM) Combined with Alimta(R) Well Tolerated in Dose-Ranging Study of Patients with Advanced Non-Small Cell Lung Cancer
9. CuraGen Announces Expansion of CR011-vcMMAE Phase II Trial in Advanced Breast Cancer
10. Advanced Life Sciences Announces Outcome of FDAs Anti-Infective Drugs Advisory Committee Review of Restanza(TM) (cethromycin)
11. PharmAthene Submits Proposal to BARDA in Response to Broad Agency Announcement for Advanced Research and Development for Valortim(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... , March 28, 2017  Akcea Therapeutics, a subsidiary ... to the company,s board of directors: ... Partners. Mr. Gabrieli will serve as chairman of the board ... former chief commercial officer of Forest Laboratories. ... Biolink Partners. "We are excited to ...
(Date:3/28/2017)... 28, 2017 RXi Pharmaceuticals Corporation (NASDAQ: ... that address significant unmet medical needs, today announced ... Japan Patent Office (JPO) for the composition of ... (CTGF) for the treatment or prevention of fibrotic ... and proliferative retinopathy (Japanese Patent #: 6060071).  This ...
(Date:3/28/2017)... , March 28, 2017  Medeon Biodesign, Inc., ... company, is pleased to announce that the Company ... of Panther Orthopedics, Inc., a San ... fixation solutions for orthopedic extremity applications.  ... expand rapidly, primarily due to procedure volume growth, ...
Breaking Medicine Technology:
(Date:3/28/2017)... ... March 28, 2017 , ... Z-Medica, LLC, ... of Pittsburgh Medical Center (UPMC) will acquire QuikClot® Bleeding Control Kits® (BCK) to ... developed in association with efforts by the American College of Surgeons, U.S. Department ...
(Date:3/28/2017)... ... 28, 2017 , ... The Radiology Business Management Association (RBMA) is ... its new executive director. Mr. Still was selected through a careful months-long search by ... he is known to our members, has been a part of building the RBMA ...
(Date:3/28/2017)... ... 28, 2017 , ... Qualidigm , the mission-driven national ... a new, more expansive office space in order to accommodate its growing number ... office building in Wethersfield, Conn. located at 936 Silas Deane Highway and immediately ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... corrosive ions found in power plant water and steam. , Chlorides and sulfates ... and boilers, leading to extensive maintenance and unplanned shutdowns. Monitoring these ions at ...
(Date:3/28/2017)... ... March 28, 2017 , ... Columbus OH. Dr. Justin ... one of few medical professionals in the country to sit on the 2017 National ... Aesthetics, in just 2 years Dr. Harper helped propel the clinic from a small ...
Breaking Medicine News(10 mins):